| Patient | Winston Churchill |
|---|---|
| Date of birth | 1874-11-30 |
| Identifiers | MRN HR-ET001-SYN-TD; SSN (made up) 000-01-8846 |
| Document date | 1953-10-07 |
| Author | Beatrice Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Three-month stroke review before returning to public speaking. [S]
Mr. Churchill returns about three and a half months after his stroke. He has been back at full days of work for two weeks and is preparing a major speech later this week. He finished physical and occupational therapy two weeks ago. He walks without a stick, writes normally, and his speech no longer slurs, though his left hand is slightly less nimble when he is tired. He has had no falls, lightheadedness, or new neurological symptoms. His mood is good and he rarely becomes tearful. He smokes about three cigars a day and drinks two or three drinks on most days. [S]
| Element | Detail |
|---|---|
| Interval change | Full work for two weeks; therapy completed |
| Function | No stick; normal writing and speech; mild left hand fatigue |
| Upcoming | A long speech later this week |
| Tobacco and alcohol | About three cigars a day; two or three drinks on most days |
| Mood | Good; rarely tearful |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Good energy; weight stable |
| Cardiovascular | Negative | No lightheadedness, chest pain, or palpitations |
| Neurological | Positive | Left hand slightly less nimble when tired; no new symptoms |
| Psychiatric | Negative | Mood good; PHQ-9 score 4 |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily for 21 days with clopidogrel | One tablet by mouth daily | Oral route | 1953-06-23 to 1953-07-14 | completed | S |
| Clopidogrel 75 mg oral tablet, one tablet by mouth daily (after a 300 mg loading dose in the hospital) | One tablet by mouth daily | Oral route | 1953-06-23 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1953-06-23 | active | S |
| Amlodipine 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1953-06-26 to 1953-07-01 | completed | S |
| Amlodipine 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1953-07-01 to 1953-07-29 | completed | S |
| Lisinopril 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1953-07-15 | active | S |
| Amlodipine 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1953-07-29 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1953-10-07 | Body height | 168 | cm | S |
| 1953-10-07 | Body weight | 78.6 | kg | S |
| 1953-10-07 | Body mass index (BMI) [Ratio] | 27.8 | kg/m2 | S |
| 1953-10-07 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1953-10-07 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1953-10-07 | Heart rate | 68 | /min | S |
| 1953-10-07 | Respiratory rate | 16 | /min | S |
| 1953-10-07 | Body temperature | 36.6 | Cel | S |
| 1953-10-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1953-10-07 | Modified rankin scale | 1 | {score} | S | ||
| 1953-10-07 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S |
Vital signs recorded on 1953-10-07; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well, vigorous, and in good humor |
| Orthostatic vital signs | Seated 126/74 mmHg; standing 122/72 mmHg |
| Heart | Regular rhythm |
| Neurological | Speech normal; faint left pronator drift; fine finger movements slightly slower on the left |
| Gait | Normal |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Mild left hemiparesis and dysarthria after a right-hemisphere lacunar infarct eight days before intake; synthetic modern episode linked to the documented 1880 stroke | active | confirmed | I69.354 | S — Synthetic modern diagnosis; the 1953 stroke remains D in the history. |
| Essential hypertension | active | confirmed | I10 | S — Synthetic diagnosis supported by the documented raised blood pressure after the 1953 stroke. |
| Nicotine dependence, cigars, six to eight a day | active | confirmed | F17.290 | S — Synthetic coded diagnosis echoing the documented lifelong cigar smoking. |
| Orthostatic hypotension after antihypertensive intensification in hot weather, resolved after reducing amlodipine | resolved | confirmed | I95.1 | S — Synthetic medication-related intercurrent problem at an unscheduled visit; it does not echo a documented illness. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure seated and standing, weight and BMI | Every visit | Completed today | Seated 126/74 mmHg, standing 122/72 mmHg; weight 78.6 kg |
| Survey | Modified Rankin Scale | At 90 days and at follow-up | Completed today | 1 at about fifteen weeks, the scheduled review nearest to 90 days |
| Survey | Depression screen (PHQ-9) | First post-stroke visit, then periodically while symptoms persist; at least yearly | Completed today | 4, in the remission range; item 9 scored 0; next at least yearly |
| Medication safety | Antithrombotic and statin adherence | Every visit | Completed today | Taking clopidogrel and atorvastatin; no bleeding |
| Laboratory | Lipid panel | 4 to 12 weeks after starting or changing a statin, then every 3 to 12 months | Up to date | LDL cholesterol 58 mg/dL in August; next within a year |
| Laboratory | Basic metabolic panel | Every 6 months on an ACE inhibitor | Up to date | Last at the end of July; due in January |
| Examination | Fall-risk assessment | Every visit | Completed today | No falls; gait normal |
| Referral | Physical and occupational therapy | Through recovery; reassess on plateau or worsening | Completed today | Discharged two weeks ago with goals met |
| Survey | Alcohol use (AUDIT-C) | Every visit | Up to date | 5 in August; repeat at the wellness visit; drinking reviewed today and advice repeated |
| Self-management | Tobacco use | Every visit | Completed today | Three cigars a day; advice to stop |
| Examination | Obstructive sleep apnea evaluation | Consider for all after stroke | Not indicated | Asked again: no snoring, witnessed apneas, or new daytime sleepiness; sleep testing still declined |
| Survey | Cognitive screen (MoCA) | Again within the first year | Due | At the annual wellness visit later this month |
| Medication safety | Influenza vaccination | Yearly | Due | At the annual wellness visit later this month |
Goal progress:
Guideline basis: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association (2021); CMID: Clinical Monitoring Intelligence Database, stroke/TIA, hypertension, and depression monographs (2026)
Follow-up: Annual wellness visit later this month. Stroke and blood pressure review in about three months. Next scheduled visit 1953-10-28: subsequent annual wellness visit. [S]